| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/16/2002 | US6372225 Tetanus toxin functional fragment antigen and tetanus vaccine |
| 04/16/2002 | US6372224 Vaccine from isolated s protein |
| 04/16/2002 | US6372223 Influenza virus vaccine composition |
| 04/16/2002 | US6372222 Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| 04/16/2002 | US6372221 Immunogenic constructs comprising flaviviruses or flavivirus derivatives |
| 04/16/2002 | US6372219 Parasite-derived anti-inflammatory immunomodulatory protein |
| 04/16/2002 | US6372217 Methods for the treatment of CD7+ viral infection with TXU-7-PAP |
| 04/16/2002 | US6372209 Vaginal lactobacillus medicant |
| 04/16/2002 | US6372208 Method of reducing an immune response to a recombinant virus |
| 04/16/2002 | US6372045 Apparatus for preparing sample cartridges for a particle acceleration device |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029074A2 Genetic immunisation against cervical carcinoma |
| 04/11/2002 | WO2002029062A2 Cytokine proteins |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002028998A2 Chlamydia pmp proteins, gene sequences and uses thereof |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028905A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028904A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028899A1 Human prostate specific g-protein receptor hpraj70 |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028892A1 Von willebrand factor-binding proteins from staphylococci |
| 04/11/2002 | WO2002028891A2 Listeria inocua, genome and applications |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028481A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | WO2002028480A2 Methods of therapy for b-cell malignancies |
| 04/11/2002 | WO2002028440A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | WO2002028430A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | WO2002028429A2 Modulation of allergic response |
| 04/11/2002 | WO2002028428A2 Vaccine composition |
| 04/11/2002 | WO2002028427A2 Pharmaceutical composition for immunisation against aids |
| 04/11/2002 | WO2002028426A1 Split enveloped virus preparation |
| 04/11/2002 | WO2002028425A2 Methods for treating muscle injuries |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028423A1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 04/11/2002 | WO2002028422A2 Split enveloped virus preparation for intranasal delivery |
| 04/11/2002 | WO2002028418A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028407A1 Methods of recovering heat shock proteins and complexes thereof |
| 04/11/2002 | WO2002028372A2 Systemic delivery of compounds through non-invasive bladder administration |
| 04/11/2002 | WO2002028371A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | WO2002028370A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | WO2002028362A2 Vaccine composition and stabilisation method |
| 04/11/2002 | WO2002028355A2 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002028188A1 Derivation of human tumor cell lines using passage in transgenic mice having selectable markers |
| 04/11/2002 | WO2002028174A1 Methods of infection with hepatitis c virus |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002012538A3 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 04/11/2002 | WO2002012288A3 Vaccination against host cell-associated herpesviruses |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092464A3 Therapeutic vaccine preparation and treatment for hiv viral infection |
| 04/11/2002 | WO2001089559A3 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine |
| 04/11/2002 | WO2001089456A3 Hybrid lt-a/ct-b holotoxin for use as an adjuvant |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001082963A3 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001066085A3 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/11/2002 | WO2001062924A3 Human g protein-coupled receptors |
| 04/11/2002 | WO2001058937A3 Interferon-alpha induced genes |
| 04/11/2002 | WO2001058477A3 Immunization of an individual against carcinoma and the preliminary stages thereof |
| 04/11/2002 | WO2001011372A9 Annexins and autoantibodies used as markers for cancer |
| 04/11/2002 | WO2000058444A9 Adaptation of virus to vertebrate cells |
| 04/11/2002 | WO2000057907A9 Multivalent dengue virus vaccine |
| 04/11/2002 | WO2000052167A9 Angiopoietin-related protein and nucleic acids |
| 04/11/2002 | WO2000042068A9 Hiv related peptides |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042127 Genetically engineered aggregation for use in the treatment of cancer |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042087 Inducing preferential cell proliferation; obtain preferential cells, incubate with modulator, monitor cell sample for proliferation activity |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020041895 Controlling particle size; foring liposomes, freeze drying, rehydration |
| 04/11/2002 | US20020041886 Veterinary medicine |
| 04/11/2002 | US20020041884 Adenovirus formulations |
| 04/11/2002 | US20020041882 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 04/11/2002 | US20020041881 Identification and characterization of novel pneumococcal choline binding protein, cbpg, and diagnostic and therapeutic uses thereof |
| 04/11/2002 | US20020041879 Using synthetic or genetic engineered antigens; embedded in biopolymer |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041873 Administering neutrotrophic factor inhibitor |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041868 Cell fusions and methods of making and using the same |
| 04/11/2002 | US20020041867 Microencapsulated dna for vaccination and gene therapy |
| 04/11/2002 | US20020041864 Method for treatment of tumors using photodynamic therapy |
| 04/11/2002 | US20020041861 Drug delivery |
| 04/11/2002 | US20020041847 Genetic engineered polypeptides |
| 04/11/2002 | CA2427842A1 Split enveloped virus preparation for intranasal delivery |
| 04/11/2002 | CA2425740A1 Modulation of allergic response by injection into a lymph node |